期刊文献+

矽肺患者血清克拉拉细胞蛋白和表面活性蛋白D的改变 被引量:15

Changes of Clara cell protein and surfactant protein-D in serum of patients with silicosis
原文传递
导出
摘要 目的 探讨矽肺患者血清克拉拉细胞蛋白(CC16)和表面活性蛋白D(SP-D)的改变。方法 以无接尘史健康体检者为对照组,按接尘史及X线胸片改变确定矽尘接触组、0组、Ⅰ期矽肺组,每组30人,采静脉血5ml,以ELISA法检测血清中CC16和SP-D含量并进行分析比较。结果矽尘接触组、0组、Ⅰ期矽肺组血清CC16含量分别为(4.54±2.10)、(3.81±1.87)和(4.04±1.87)ng/ml,明显低于对照组。差异有统计学意义(P〈0.01);对照组内不吸烟人群的血清CCl6含量高于吸烟人群,差异有统计学意义(P〈0.05),矽尘接触组、0^+组且、Ⅰ期矽肺组之间血清CCl6含量差异无统计学意义(P〉0.05)。0^+组、Ⅰ期矽肺组血清SP-D含量分别为(47.41±16.78)和(110.33±54.22)ng/ml,明显高于对照组和矽尘接触组,差异均有统计学意义(P〈0.05或P〈0.01);Ⅰ期矽肺组血清SP-D含量高于0^+组,差异有统计学意义(P〈0.01)。以血清CC16和SP-D建立判别分析方程,对对照组、矽尘接触组、Ⅰ期矽肺组的正确判别率分别为86.7%、86.7%、76.7%,总体判别效率为84.2%。结论 长期暴露于矽尘环境下的工人血清CC16含量降低,而SP-D量进行性升高。 bjective To explore the changes of Clara cell protein (CC16) and the surfactant protein-D (SP-D) in the serum of patients with silicosis. Methods The concentrations of CC16 and SP-D were measured in the serum by sandwich enzyme-linked immunosorbent assays. The subjects consisted of 30 healthy volunteers and 90 silica-exposed workers including the silica-exposed group, the silicosis suspects group(0^+) and the silicosis phase Ⅰ group, 30 subjects each group. Results The concentration of CC16 in the serum was significantly decreased in silica-exposed workers compared with controls (P〈0.01); The concentration of CC 16 in the serum was higher in lifelong nonsmokers than the current smokers in control subjects (P〈0.05), but there were no differences between lifelong nonsmokers and current smokers of 90 silica-exposed workers. Compared with control subjects, the levels of SP-D in the serum of silicosis suspects (0^+) and silicosis phase Ⅰ groups were signiiicantly elevated (P〈0.01, respectively), which were also higher than the silica-exposed group (P〈0.05 and P〈 0.01, respectively). Discriminant equations set by CC16 and SP-D were used in diagnosis of silicosis, and the rate of accuracy in healthy volunteers, the silica-exposed group and the silicosis phase I group were 86.7%, 86.7% and 76.7%, respectively. The total rate of correct classification hit 84.2%. Conclusion The serum CC16 of long-term silica-exposed workers is decreased, and SP-D is increased gradually.
出处 《中华劳动卫生职业病杂志》 CAS CSCD 北大核心 2007年第1期18-21,共4页 Chinese Journal of Industrial Hygiene and Occupational Diseases
基金 天津市科技攻关培育项目(0331060111)
关键词 克拉拉细胞蛋白 表面活性蛋白D 矽肺 Clara cell protein Surfactant proteinD Silicosis
  • 相关文献

参考文献14

  • 1Bernard AM,Gonzalez-Lorenzo JM,Siles E,et al.Early decrease of serum Clara cell protein in silica-exposed workers.Eur Respir J,1994,7:1932-1937.
  • 2Crouch E,Persson A,Chang D,et al.Surfactant protein D increased accumulation in silica-induced pulmonary lipoproteinosis.Am J Pathol,1991,139:765-776.
  • 3聂小蒙,李强.Clara细胞蛋白-CC16[J].国外医学(呼吸系统分册),2004,24(2):97-99. 被引量:18
  • 4章晓红,王曾礼.Clara细胞蛋白与肺部疾病[J].国外医学(呼吸系统分册),2002,22(1):49-51. 被引量:12
  • 5Suzuki E,Takahashi Y,Aida S,et al.Alteration in surface of Clara cells and pulmonary cytochrome P-450 level in rats exposed to ozone.Toxicology,1992,71:223-232.
  • 6Evans MJ,Cabral-Anderson LJ,Freeman G.Role of Clara cells in the renewal of bronchiolar epithelium.Lab Invest,1978,38:648-655.
  • 7Hermans C,Bernard A.Lung epithelium-specific proteins.Am J Respir Crit Care Med,1999,159:646-678.
  • 8Francis XM,Jeffrey AW.The pulmonary collectins,SP-A and SPD,orchestrate innate immunity in the lung.J Clin Invest,2002,109:707-712.
  • 9Mason RJ,Greene K,Dennis RV.Surfactant protein A and surfactant protein D in health and disease.Am J Physiol,1998,275 (Lung Cell Mol Physiol 19):L1-L13.
  • 10Kishore U,Bernal AL,Kamran MF,et al.Surfactant proteins SP-A and SP-D in human health and disease.Arch Immunol Ther Exp,2005,53:399-417.

二级参考文献33

  • 1-kDa protein are decreased in patients with asthma. Lung,1999,177:45-52.10.Lensmar C, Nord M, Gudmundsson GH, et al. Decreased pulmonary levels of the anti inflammatory Clara cell 16 kDa protein after induction of airway inflammation in asthmatics.Cell Mo
  • 2Arsalane K, Broeckaert F, Knoops B, et al. Clara cell specific protein (CC16) expression after acute tung inflammation induced by intratraeheal lipopolysaecharide administration. Am J Respir Grit Care Med, 2000,161:1624-1630.
  • 3Shijubo N, Itoh Y, Yamaguchi T, et al. Development of an enzyme-linked immunosorbent assay for Clara cell 10-kDa protein: in pursuit of clinical significance of sera in patients with asthma and sarcoidosis. Ann N Y Acad Sci, 2000,923: 268- 279.
  • 4Shijubo N, Itoh Y, Abe S. Anti-inflammatory molecule, Clara cell 10 kilodalton protein and respiratory diseases. Rinsho Byori,2002,50:370-373.
  • 5Reynolds SD,Mango GW,Gelein R,et al. Normal function and lack of fibronectin accumulation in kidneys of Clara cell secretory protein/uteroglobin deficient mice. Am J Kidney Dis,1999,33:541-551.
  • 6Hayashida S, Harrod KS, Whitsett JA. Role of Clara cell secretory protein in the endotoxin-induced neutrophil migration into the lung (Abstract). Am J Respir Crit Care Med, 2000,161:A847.
  • 7Shijubo N,Itoh Y,Yamaguchi T,et al. Serum levels of Clara cell
  • 8Laing IA, Hermans C, Bernard A, et al. Association between plasma CC16 levels,the A38G polymorphism,and asthma. Am J Respir Crit Care Med,2000,161:124-127.
  • 9Pilon AL. Rationale for the development of recombinant human CC10 as a therapeutic for inflammatory and fibrotic disease. Ann N Y Acad Sci,2000,923:280-299.
  • 10Hermans C, Bernard A. Lung epithelium-specific proteins:characteristics and potential applications as markers. Am J Respir Crit Care Med, 1999,159: 646-678.

共引文献19

同被引文献120

引证文献15

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部